MedTrace Logo

Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy

NCT02417779 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2023-02-24

No results posted yet for this study

Summary

In plastic and reconstructive surgery, treatment strategies of second-degree burns, superficial wounds, hypertrophic burn scars, flaps and chronic wounds aim at reducing infection and improving microcirculation. Although previous studies indicate that extracorporeal shock wave therapy (ESWT) can accelerate wound healing, only a few studies focused on the elucidation of its mechanisms of action. Therefore, the aim of this study is to evaluate the microcirculatory effects of extracorporeal shock wave therapy on second-degree burns, superficial wounds, hypertrophic burn scars, flaps and chronic wounds in a human in-vivo setting for the first time.

Conditions

  • Burn Injury
  • Acute Wound
  • Chronic Wound
  • Burn Scar
  • Flap Disorder

Interventions

DEVICE

Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)

Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)

DEVICE

Repetitive Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)

Repetitive Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)

Sponsors & Collaborators

  • University Hospital Schleswig-Holstein

    lead OTHER

Principal Investigators

  • Tobias Kisch, MD · University Hospital Schleswig-Holstein

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2023-02-28
Completion
2023-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02417779 on ClinicalTrials.gov